CCDC77 Down (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with CCDC77 Down.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with CCDC77 Down.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with CCDC77 Down.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with CCDC77 Down.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000148572 - nuclear receptor binding factor 2

Gene

ENSG00000147509 - regulator of G protein signaling 20

Gene

ENSG00000166128 - RAB8B, member RAS oncogene family

Gene

ENSG00000137947 - general transcription factor IIB

Gene

ENSG00000170222 - ADP-ribose/CDP-alcohol diphosphatase, manganese dependent

Gene

ENSG00000119878 - CXXC repeat containing interactor of PDZ3 domain

Gene

ENSG00000100568 - vesicle transport through interaction with t-SNAREs 1B

  • Gene

    ENSG00000148572 - nuclear receptor binding factor 2


  • Gene

    ENSG00000147509 - regulator of G protein signaling 20


  • Gene

    ENSG00000166128 - RAB8B, member RAS oncogene family


  • Gene

    ENSG00000137947 - general transcription factor IIB


  • Gene

    ENSG00000170222 - ADP-ribose/CDP-alcohol diphosphatase, manganese dependent


  • Gene

    ENSG00000119878 - CXXC repeat containing interactor of PDZ3 domain


  • Gene

    ENSG00000100568 - vesicle transport through interaction with t-SNAREs 1B

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.